Presentations

Upcoming presentations

2025-06-16 - BIO International Convention i Boston, USA

2025-06-20 - American Diabetes Association (ADA) Scientific Sessions i Chicago, USA

2025-07-14 - Controlled Release Society (CRS) Annual Meeting i Philadelphia, USA

Past presentations

2025-06-03 - DDF Summit, Drug Delivery & Formulation i Berlin

2025-05-06 - Q1 report commentary with CEO David Westberg

2025-02-19 - Q4 report commentary with CEO David Westberg and Chairman of the board Göran Ando

2025-02-13 - Extraordinary General Meeting

2024-11-28 - Stora Aktiedagarna Stockholm 28 november

2024-11-25 - Phase I study for NEX-22 result presentation and Q&A

2024-11-07 - Webbcast with report commentary with CEO David Westberg and Chairman of the board Göran Ando

2024-09-06 - AFRY Breakfast Broadcast with Mårten Rooth

2024-08-27 - Report interview Q2 with CEO David Westberg

2024-05-23 - Redeye Diabetes Event

2024-05-22 - Nanexa – Investor Days May 22-23

2024-05-07 - Capital markets day at the Royal Swedish Academy of Engineering Sciences IVA in Stockholm

2024-03-08 - ABG Sundal Collier – Fireside chat with CEO David Westberg

2024-02-21 - Webbcast with report commentary at 11:30 am with CEO David Westberg.

2023-11-20 - Webbcast with report commentary at 3:00pm with CEO David Westberg and Chairman Göran Ando.

2023-10-24 - Aktieportföljen Live, CEO David Westberg presents

2023-10-19 - Nanexa Redeye Investor Forum Online, CEO David Westberg presents

2023-10-09 - Investor meeting and lunch, at 10 am to 13 pm, with Chairman Göran Ando, CEO David Westberg and the rest of the management team, at Uppsala Business Park.

2023-10-09 - Aktiespararna, Aktiedagen Lund, CEO David Westberg presents

2023-10-04 - Redeye interview with CEO David Westberg